AAAAAA

   
Results: 1-7 |
Results: 7
Pattern formation in non-Newtonian Hele-Shaw flow
Authors: Fast, P Kondic, L Shelley, MJ Palffy-Muhoray, P
Citation: P. Fast et al., Pattern formation in non-Newtonian Hele-Shaw flow, PHYS FLUIDS, 13(5), 2001, pp. 1191-1212
A Phase I safety and immunogenicity trial of UBI (R) microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects
Authors: Lambert, JS Keefer, M Mulligan, MJ Schwartz, D Mestecky, J Weinhold, K Smith, C Hsieh, R Moldoveanu, Z Fast, P Forrest, B Koff, W
Citation: Js. Lambert et al., A Phase I safety and immunogenicity trial of UBI (R) microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects, VACCINE, 19(23-24), 2001, pp. 3033-3042
QS-21 promotes an adjuvant effect allowing for reduced antigen dose duringHIV-1 envelope subunit immmunization in humans
Authors: Evans, TG McElrath, MJ Matthews, T Montefiori, D Weinhold, K Wolff, M Keefer, MC Kallas, EG Corey, L Gorse, GJ Belshe, R Graham, BS Spearman, PW Schwartz, D Mulligan, MJ Goepfert, P Fast, P Berman, P Powell, M Francis, D
Citation: Tg. Evans et al., QS-21 promotes an adjuvant effect allowing for reduced antigen dose duringHIV-1 envelope subunit immmunization in humans, VACCINE, 19(15-16), 2001, pp. 2080-2091
A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection
Authors: McElrath, MJ Corey, L Montefiori, D Wolff, M Schwartz, D Keefer, M Belshe, R Graham, BS Matthews, T Wright, P Gorse, G Dolin, R Berman, P Francis, D Duliege, AM Bolognesi, D Stablein, D Ketter, N Fast, P
Citation: Mj. Mcelrath et al., A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection, AIDS RES H, 16(9), 2000, pp. 907-919
Brodsky as a critic and translator of Milosz
Authors: Fast, P
Citation: P. Fast, Brodsky as a critic and translator of Milosz, RUSS LIT, 47(3-4), 2000, pp. 331-344
A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with Rgp120 elicits broad and durable CD8(+) cytotoxic T lymphocyte responses in seronegative volunteers
Authors: Evans, TG Keefer, MC Weinhold, KJ Wolff, M Montefiori, D Gorse, GJ Graham, BS McElrath, MJ Clements-Mann, ML Mulligan, MJ Fast, P Walker, MC Excler, JL Duliege, AM Tartaglia, J
Citation: Tg. Evans et al., A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with Rgp120 elicits broad and durable CD8(+) cytotoxic T lymphocyte responses in seronegative volunteers, J INFEC DIS, 180(2), 1999, pp. 290-298
Preventing discrimination against volunteers in prophylactic HIV vaccine trials: Lessons from a phase II trial
Authors: Sheon, AR Wagner, L McElrath, MJ Keefer, MC Zimmerman, E Israel, H Berger, D Fast, P
Citation: Ar. Sheon et al., Preventing discrimination against volunteers in prophylactic HIV vaccine trials: Lessons from a phase II trial, J ACQ IMM D, 19(5), 1998, pp. 519-526
Risultati: 1-7 |